Quick Answer
Aptose Biosciences Inc. reported Stockholders Equity of -$27.17 million for fiscal year 2025.
Aptose Biosciences Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$27.17M | -498.0% |
| 2024 | -$4.54M | -56.6% |
| 2023 | -$2.90M | -107.7% |
| 2022 | $37.74M | -49.2% |
| 2021 | $74.24M | -37.6% |
| 2020 | $118.92M | +26.6% |
| 2019 | $93.93M | +567.0% |
| 2018 | $14.08M | +38.0% |
| 2017 | $10.20M | +39.2% |
| 2016 | $7.33M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$19.45M | -112.9% | -35.3% |
| June 30, 2025 | -$14.37M | -560.4% | -94.4% |
| March 31, 2025 | -$7.39M | -5496.4% | -62.7% |
| December 31, 2024 | -$4.54M | -56.6% | +50.3% |
| September 30, 2024 | -$9.13M | -217.5% | -319.8% |
| June 30, 2024 | -$2.18M | -115.8% | -1688.3% |
| March 31, 2024 | $137.0K | -99.5% | +104.7% |
| December 31, 2023 | -$2.90M | -107.7% | -137.3% |
- Aptose Biosciences Inc. showed a decrease of -498.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Aptose Biosciences Inc.’s stockholders equity has declined by 470.7% (from $7.33 million to -$27.17 million).
- The most recent figure is from Aptose Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: